Summary of Bliss scores and sensitivity to dinaciclib, navitoclax and combination treatment.

1

Synergy analysis after 18 hr treatment. vBliss: synergy (>0.1), additive (0.1–0.05). neutral (<0.05-0), antagonistic (<0).

2

Percent viability after 18 hour treatment with 100 nM dinaciclib, 1 µM navitoclax or the combination.

3

Information source. Cancer Cell Line Encyclopedia converted from log 2 to log10.

Summary of Bliss scores and sensitivity to dinaciclib, navitoclax and combination treatment.